Hormonal treatments for endometriosis primarily target ESR1, ESR2, or PGR and have the highest affinity for these receptors; however, due to the structural similarity of hormone receptors, off-target effects at other receptors are possible [32]. The gene discussed is PGR; the disease is endometriosis.